Loading clinical trials...
Loading clinical trials...
This is a mixed-methods Hybrid Type 1 research design (efficacy study) in which we aim to conduct a two-arm randomized controlled trial and an Implementation Focused Process Evaluation of a culturally...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Georgetown University
Collaborators
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT03124212 · Hereditary Breast and Ovarian Cancer, Lynch Syndrome
NCT02516540 · Hereditary Breast and Ovarian Cancer
NCT05677048 · Gynecologic Cancer, Ovary Cancer, and more
NCT03246841 · Hereditary Breast and Ovarian Cancer, Mutation
Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia
Virginia Commonwealth University
Richmond, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions